Combinatorial gene inactivation using an RNAi library is a powerful approach to discovering novel functional genes. However, generation of a comprehensive RNAi library remains technically challenging. In this report, we describe a simple and novel approach to designing gene-familyspecific RNAi libraries by targeting conserved motifs using degenerate oligonucleotides. We created an siRNA library in the pHUMU vector using partially randomized sequences targeting the consensus region in the ZnF_C4 signature motif of the nuclear hormone receptors and thus against the entire receptor superfamily. For proof of principle, we adapted a reporter assay to screen this library for receptors that might be involved in reducing amyloid β peptide accumulation. We modified a previously described luciferase reporter assay to measure the amyloid β precursor cleavages occurring only between β-and γ-secretase cleavage sites, thus excluding the major γ-secretase activities that could generate neurotoxic Aβ peptides. Our screen using this assay identified siRNA vectors that specifically increase the Aβ40/42 cleavage and pointed to a potential receptor target, ROR-γ. SiRNAs targeting other regions of ROR-γ not only confirmed the observed reporter activity but also reduced the level of the toxic Aβ peptides. The results demonstrated a general principle for the creation and application of this RNAi library approach for functional gene discovery within a predefined protein family. The discovered negative effect of ROR-γ on the degradation of the toxic Aβ peptides may also provide a potential drug target or targetable pathway for intervention of Alzheimer disease.
Therapeutic targets are generally gene products whose inactivation reverses disease phenotype or slows down disease progression. RNAi efficiently inhibits gene expression and thus mimics many drug effects. Combinatorial gene inactivation using RNAi libraries has recently become a method of choice to investigate gene function or identify new therapeutic targets [1] [2] [3] [4] . RNAi libraries can be delivered as short double-stranded RNA in an arrayed form or in gene expression vectors in an arrayed [4] or pooled format [5] [6] [7] . In the first case, siRNAs against a large panel of gene targets derived from specific gene families or pathways were chemically synthesized individually in an arrayed form (e.g., 96-well format). This approach has been broadly used in high-throughput discovery of functional genes, and many such libraries have become available from commercial sources. The major limitation of this approach is the high cost of the repeated synthesis of a consumable complex library. Also, synthetic siRNA is not suitable for cotransfection experiments with reporter DNA plasmids. In the second case, RNAi library vectors are constructed either by PCR [4] or by cloning (plasmid vectors and viral vectors) [1, 2, 8] . These are renewable and suitable for cotransfection with other vectors (e.g., reporters) [3, 9] . However, technical challenges still remain for the creation of such libraries, thus limiting their application. We recently described a special RNAi vector based on a dual opposing promoter siRNA expression cassette (pMUHU) that can be used to construct an siRNA vector readily by a "single-parallel cloning process," facilitating highthroughput screening using a reporter cotransfection [3] .
There are several methods of designing RNAi vector libraries with regard to their targets. The first approach is to construct individual siRNAs against defined sequences of each target (usually up to four siRNA per gene), a labor-intensive process if a large number of gene targets are involved. The second potential approach is to generate a combinatorial library by randomizing the entire siRNA sequences, thus covering every possible gene, similar to the randomized ribozyme libraries described previously [10] [11] [12] . However, the fully randomized siRNA library, with 21 nucleotides in length, would have a complexity of 2.2 × 10 12 , far exceeding the complexity of the mammalian genome, and would not be practical to use. The third approach is to clone short double-stranded cDNA sequences of 21-27 bp directly into expression vectors. There are reports of successful examples using this strategy [5] [6] [7] , but the efficiency of construction and the representativeness of these libraries are still not optimal.
We are interested in studying specific gene families, particularly those considered druggable. We devised an extremely simple and cost-effective method for expressing a library of siRNAs targeting all the genes encoding a predetermined protein family. Many protein families are characterized by one or more signature motifs of a highly conserved domain(s) critical for the biochemical functions of the family, e.g., the kinase domain for kinases. Our method is based on the design of semirandomized, degenerate oligonucleotides that target the conserved domains of the gene family.
Nuclear hormone receptors (NHRs) are transcription factors with certain structural and functional characteristics [13, 14] . The family of NHRs contains 45 known members and possibly additional unknown members. All members contain two conserved signature motifs: the zinc finger_C4 domain (ZnF_C4 or C4 zinc finger) and the HOLI (hormone ligand) motif. These two domains coordinate with each other and thus are responsible for switching on/off or up/downregulating the expression of the targeted genes. The ZnF_C4 motif is located inside the DNA binding domain of NHRs and determines the DNA-binding specificity for a given NHR, while the HOLI motif is located within the ligand binding domain of NHRs and determines the ligand specificity of a given NHR. In this proof-of-principle study, we designed and constructed an siRNA library against human NHRs using the degenerate sequences derived from the signature motif ZnF_C4 of NHRs.
Alzheimer disease (AD) is the most prevalent neurodegenerative disease. During AD progression, protein deposits known as "amyloid" form between neurons within senile plaques and cerebral blood vessels. The formation of amyloid plaques is believed to contribute to the degradation of neurons and subsequent AD development [15] . The principal proteinaceous component of the toxic amyloid is the amyloid β peptides around 40 kDa in size. These Aβ species with varying carboxyl termini, commonly known as Aβ40 and Aβ42, are generated from the amyloid β precursor protein (APP) through sequential proteolytic cleavages, mainly through the combined actions of β-and γ-secretases. Aβ42 is considered the main neurotoxic component. Certain enzymes have recently been implicated in the degradation of the toxic Aβ [16] . It is widely believed that any mechanism causing a reduction in the toxic Aβ cleavage products, either by reducing its formation or by increasing its degradation, would provide benefit to the treatment of AD.
We were interested in identifying gene targets whose inactivation reduces the toxic Aβ42 fragment. A robust 96-well format screening assay that measures the degradation of the Aβ peptides would facilitate this effort. Although enzymelinked immunosorbent assays (ELISAs) to measure Aβ40 and Aβ42 levels directly and specifically are commercially available, they are not sufficiently sensitive and reliable as a screening tool in combination with RNAi library vector transfection due to low and variable transfection efficiency, as well as transfection-associated cytotoxicity. Komano et al. recently described a novel luciferase reporter assay for APP cleavage [17] . This assay employs a recombinant protein containing a portion of APP fused to the mouse Notchintracellular domain (NICD). Cleavage of this recombinant protein within APP domain by γ-secretase or other proteases allows the translocation of the NICD to the nucleus, where it activates the firefly luciferase reporter ( Fig. 2A) . γ-Secretase cleaves at positions 40 and 42 to generate Aβ40 and the toxic Aβ42. However, γ-secretase is not considered a good drug target since it plays many vital cellular functions. For instance, it also cleaves Notch, an essential molecule for neurological function [16] . We are therefore interested in activities that cleave upstream of the major γ-secretase sites and that are responsible for the degradation of the toxic Aβ peptides (Fig. 2B, 1) .
In this study, we have developed a unique reporter assay to measure the cleavage (or degradation) activities of the toxic Aβ peptides and used this to screen the NHR siRNA library for receptors whose silencing would lead to reduction of the toxic Aβ peptides. Our screen identified ROR-γ (retinoic acid receptor (RAR)-related orphan receptor) as a novel target. ROR-γ had not been linked to Aβ degradation previously. This discovery not only revealed potential new mechanisms and therapeutic opportunities for AD, but also demonstrated the utility of this NHR and other similarly constructed siRNA libraries.
Results
Construction of an siRNA library targeting the human nuclear hormone receptor family using degenerate sequences against ZnF_C4 consensus sequences Database searches revealed 45 unique proteins containing both ZnF_C4 and HOLI domains, most of them being previously described as NHRs and the few remaining being hypothetical ones. There are also >100 known or hypothetical proteins with only one of the two conserved motifs. The present study focuses only on the 45 members with both domains. We set out to design siRNA against the relatively more conserved ZnF_C4 domain. We aligned the 45 unique protein sequences and identified, in the ZNF_C4 domain, three conserved motifs of 7 or 8 amino acids with the following sequences, in which x stands for amino acids that are not completely conserved in all 45 proteins and C stands for the cysteine amino acid that is conserved in all 45 proteins: (1) CxxFFxRx, (2) xCxxxCxF, and (3) xCxxC(K/S)x. These motifs are sufficiently long for a functional siRNA (21-24 bp) . The presence of the constant Phe (F) in the first two motifs negates their usefulness, since phenylalanine is coded by TTT or TTC, which triggers a termination signal for the Pol III promoter. Therefore, the third consensus sequence was chosen to design the NHR siRNA library. Careful comparison of this motif with all 45 known members indicates that some x residues are not totally random. The actual consensus amino acid sequence is represented by ( [10] [11] [12] 22] . However, the majority of the members are still superfluous.
To reduce the complexity of the library further, we subdivided the 45 proteins into nine groups, each comprising members having a relatively higher number of constant amino acids than that of the entire family (see Table 1 ). Due to the codon redundancy and the genetic shift in the evolutionary course, the same amino acid sequences do not necessarily correspond to the same nucleotide sequences. Therefore, we aligned the nucleotide sequences encoding the motif from individual members directly to determine the conserved and variable positions for the nine subgroups. In this way, we generated an siRNA library of a total complexity of 1656 (see Table 2 ). This complexity, although still including many superfluous siRNAs, is sufficiently low for efficient cloning and downstream biological screening.
The nine degenerate oligonucleotides and the flanking sequences were chemically synthesized (Fig. 1A ) [3] . These oligomers were pooled together according to their representation within the NHR family. The sense-strand siRNA oligonucleotides were annealed with the two adapter oligonucleotides and subsequently ligated into the pHUMU vector to yield the pHUMU-siNR library vector with a partial single strand at the degenerate siRNA coding sequences (N 21 ) (Fig.  1A ) [3] . The ligated vectors were transformed into bacteria, allowing the bacteria to fill in the single-stranded gap [3, 10] . The final structure of the pHUMU-siNR-Lib vector contains an siRNA expression cassette consisting of opposing human and murine U6 promoters driving both sense and antisense strands of siRNA transcription, both with the initiation Table 2 Oligos of the NHR-siRNA library
The underlined letters are nucleotide symbols, while those beneath the lines are the one-letter abbreviations for amino acids. Each underlined unit stands for a codon.
nucleotide G (+1), and the termination sequence CTTTTT, where C (+23) is complementary to the G (+1) of the antisense siRNA gene and the five T's constitute the termination signal [3] . Transcription of the siRNA will terminate after two T's ( Fig. 1A) . This creates the 25-nucleotide coding sequence for the siRNA library: GN 21 CTT (Fig. 1A) . The most salient feature of the pHUMU vector is the simplicity in constructing such an siRNA library [3] . Sequencing of 50 clones from the constructed library showed that they all contained distinct sequences, confirming the partial randomness of the library surrounding the consensus sequences (data not shown). The siRNA library cassette could then be subcloned into a variety of vectors for different uses. To facilitate the luciferase-based reporter assay for functional screening, we further arrayed the pHUMU-siNR library into five 96-well plates with each well containing 10 clones. A total of 4800 colonies were arrayed, which is equivalent to three times the maximal complexity of the library. The arrayed plates should thus cover every NHR member with high probability. During transient cotransfection, cells take up large amounts of DNAs and thus each transfected cell should take up all 10 siRNA vectors. To determine how much dilution of the functional plasmid DNA was tolerable, we tested luciferase silencing by cotransfection of HeLa cells with the firefly luciferase reporter plasmid and different inputs of the pHUMU-siLuc vector (at 1:1 to 1:10 ratios to pHUMU-siCTL). Our result demonstrated that the luciferase silencing was effective even when the vectors were diluted 10-fold (Fig. 1B) , which indicates that the format of 10 different vectors in 1 well seems adequate.
Modified luciferase reporter assay for the cleavage of toxic Aβ peptides
We set out to modify the luciferase-based APP cleavage assay developed by Komano et al. to measure protease cleavage upstream of major γ-secretase sites. First, we modified the original pC53NICD construct to create pNotch-Aβ (Fig. 2B, 1 ) in which the two dominant γ-secretase cleavage sites were removed by mutating two amino acids at positions 41 and 42 (from IA to MV) in the APP protein (Fig. 2B, 1 ). This should exclude the readout for Aβ formation and retain the readout for Aβ degradation. Second, a murine Ig κ-chain V-J2-C signal peptide and hemagglutinin A epitope (HA) were added to the Nterminus (Fig. 2B, 1) . The added signal peptide helps to ensure targeting of all fusion proteins to the membrane, thus reducing the background nucleus translocation. An HA tag was added for easy cell surface detection. Aβ40/42-specific ELISA confirmed that Aβ42 production was completely abolished and the Aβ40 production was reduced by half in the mutant when both wildtype amyloid precursors (APP695wt) and mutant APP695MV were tested in HEK293T cells by transient transfection (data not shown). These mutations also significantly reduced the luciferase activities resulting from pNotch-AβMV cleavage to one-seventh of that of the wild-type pNotch-Aβ (Fig. 2C) , further proving that the MV point mutations resulted in reduction of APP cleavage by γ-secretase. A Renilla luciferase reporter was cotransfected to control for transfection efficiency. Thus, an increase in degradation of Aβ40 and Aβ42 is reflected by an increase in the ratio of firefly to Renilla luciferase signal. The vector systems for cotransfection luciferase assay. 1 + 2: pNotch-AβMV + pHES-Luc, a modified reporter system for Aβ cleavage. 3: Renilla luciferase internal control vector. 4: pHUMU (vector) (pHUMUsiNL_library). The structure of the opposing promoter siRNA gene expression cassette was described previously by Yu et al. [21] . (C) Significantly reduced background for Aβ cleavage by γ-secretase through a mutation that removes γ-secretase cleavage sites. (D) Assay validation using the genes known to promote Aβ cleavage. NEP (neprilysin), PSN (presenilin), and IDE (insulin-degrading enzyme) expression plasmids were cotransfected into HEK293T cells along with the luciferase reporter system. The relative luciferase activities compared to control vector are represented.
Our observation also suggests that the majority of APP cleavage in this cell system resulted from the two dominant γ-secretase activities, leading to the production of the toxic Aβ peptides.
A number of enzymes are known to reduce levels of the Aβ40/42 peptide species, including neprilysin (NEP), presenilin (PSN), insulin-degrading enzyme (IDE), angiotensin-converting enzyme, and matrix metalloprotease-9 (MMP-9), which cleave upstream of the dominant γ-secretase sites (Fig. 2B, 1) [16] . To validate our assay, we cotransfected NEP, PSN, or IDE expression plasmids with the new reporter system (Fig. 2B,  plasmids 1, 2, 3 ) into HEK293T cells. We observed an increase in the firefly luciferase signal with expression of all three enzymes, up to 200% over the endogenous protease levels (Fig.  2D) . It is worth pointing out that without the introduced mutations, the background reading is too high for detecting these activities due to the endogenous γ-secretase activities (data not shown). We also adapted this assay to a 96-well format for screening siRNA and cDNA libraries as well as compound libraries (C. Rogers et al., unpublished data).
Identification of NHRs involved in the APP cleavage upstream of γ-secretase sites
We screened the pHUMU-NHR-siRNA library using the Aβ degradation reporter assay in 96-well plates. HEK293T cells in each well were cotransfected with pNotch-AβMV, pHES-Luc, and SV40-Renilla plasmids (Fig. 2B, 1, 2, and 3 ) and pHUMUsiNR-Lib (Fig. 1A or 2B, 4) . Each transfection was in triplicate. Luciferase activity was measured 2 days posttransfection. A total of five 96-well plates with 4800 clones in 480 wells were screened. Ten wells demonstrating >30% increase in the ratio of firefly to Renilla luciferase signals for the siRNA library over the control vector were considered as initial "hits." Repeating the test of the 10 pooled hits confirmed 6 of them with >30% increase in luciferase signaling. These 6 pools were then deconvoluted to identify the functional siRNA vectors by testing individual siRNA vectors using the same assay. In the end, a total of four siRNA vectors were shown to have statistically significantly increased luciferase signal (Fig. 3A) , with some of the clones being redundant vectors found in different positive pools.
The sequences of these final four siRNA vectors were used to identify four potential candidate NHR targets (see Table 3 ): NR4A2, NR113, ROR-γ (RAR-related orphan receptor-γ or RORC or NR1F3), and NR6A1 by the BLASTN nr database (NCBI). All these siRNAs contain 100% continuous homology across >16 bp of siRNA sequences in the center with the candidate targets (see Table 3 ). As an example, the transcript of siRNA vector ID4_16 has a 17-nucleotide perfect match with the RORC nucleotide positions 250-267 and an additional match at position 247 of RORC (Fig. 3B) . As is known, a mismatch, or lower internal thermostability, at the 5′ end of the antisense strand of siRNA not only is tolerated, but also can potentially enhance the potency of RNAi [23, 24] . Therefore, RORC could be a potential target for the siRNA vector ID 4_16.
To confirm whether these candidate receptors were truly responsible for the expected phenotypes, we repeated the experiments using chemically synthesized siRNA designed against unique regions of each of the four NHR sequences outside the Zn_F_C4 region. Two siRNAs for each candidate target (except only one siRNA for NR4A2) were used in the study. Our data confirmed that the siRORC-1 mediated ROR-γ silencing (Fig. 4A ) and increased luciferase reporter activity by nearly 250% (Fig. 3C) . RORC-2 siRNA did not down-regulate RORC (Fig. 4A) and did not cause elevated luciferase activity (Fig. 3C) . This strong correlation between the increase in luciferase activity and the RORC silencing suggests that RORC likely influences the degradation of the Aβ peptides upstream of the γ-secretase sites. On the other hand, the siRNAs against the other three potential candidates (Table 3) did not confirm that the increase in reporter activities correlated with gene silencing, suggesting that these three receptors are unlikely to be involved in Aβ degradation (Fig. 3C) . The effects observed by the siRNA vectors from the library likely resulted from other undetermined targets.
Retinoic acid is reported to be a natural agonist ligand for RORC [14] . If RORC is involved in Aβ cleavage, retinoic acid treatment should therefore down-regulate the cleavage, in contrast to the RORC silencing. We treated the cells with retinoic acid and assayed for luciferase reporter activity. Indeed, we observed that this treatment lowered reporter activity (Fig.  3D ). This suggests that retinoic acid causes a reduction in Aβ cleavage via RORC at physiological concentration [25] , consistent with our RNAi experiments. However, we should also realize that retinoic acid is a ligand for many other receptors and not specific for RORC. Therefore, this particular experiment cannot rule out that the retinoic acid effects resulted from a mechanism other than RORC.
Confirmation of ROR-γ involvement in Aβ degradation
There are at least two mechanisms that determine the ultimate output of the toxic Aβ peptides: Aβ formation by γ-secretase cleavage and Aβ degradation by other activities upstream of these two sites. To determine if siRNA-mediated ROR-γ silencing actually resulted in degradation of the Aβ peptides, we assessed Aβ42 production in ID11 cells with or without siROR-γ treatment, using the Aβ42-specific ELISA. ROR-γ siRNA was transfected into ID11 cells and the culture media were assayed for Aβ42 by ELISA. To control for toxicity induced by the expression of various siRNAs, a WST assay was also carried out in parallel. No significant toxicity was found for any of the siRNAs expressed (data not shown). Real-time RT-PCR (TaqMan) revealed 80% knockdown of the ROR-γ mRNA mediated by the siRORC-1 (Fig. 4A) . These transfected cells also demonstrated consistent reduction of Aβ42 by nearly 20% (Fig. 4B ). siRORC-2, which did not knock down ROR-γ expression, also did not decrease Aβ42 expression. These results confirmed that the increase in cleavage occurring upstream of the major γ-secretase sites over the basal level can actually be translated into a reduction in the toxic Aβ peptides. The 20% reduction at the peptide level is significant, considering that the toxic peptides are generated mainly by γ-secretase activities that account for the dominant cleavages of APP in cells, while the activities of the other cleavage enzymes are relatively minor (compare Figs. 2C and 2D ).
Discussion
We have described a new and simple method to design and create RNAi libraries against any gene family that contains a conserved sequence motif. The RNAi libraries thus generated can be delivered either in an opposing promoter siRNA expression cassette, as described in this report, or in a short hairpin RNA expression cassette [26] (Zhou, unpublished data). Most protein families are usually classified according to the characteristic functional domains consisting of conserved motifs at the amino acid level, which are further reflected by a certain degree of consensus sequences at the nucleic acid level. These families include phosphatases, protein kinases, metalloproteases, transferases, GTPases, ATPases, etc. There are a few exceptional gene superfamilies, notably G-proteincoupled receptors, that apparently lack such conserved domains. However, there may still be certain conserved motifs for some of their subfamilies. The existence of consensus sequences makes it possible to design partially randomized RNAi libraries targeting these predetermined families of proteins. There is complete flexibility in the library design in terms of the degree of randomization. A higher degree of randomization covers more potential permutations of the gene sequence but increases library complexity and thus the downstream workload. We have demonstrated two important approaches to reduce the complexity while maintaining representation in member coverage in this report. First, a protein family is divided into subgroups in which the degree of consensus among the subgroup members is significantly higher than that among the subgroups. The complexity of the library is inversely correlated to the degree of subdivision of the protein family and also to the total number of siRNA oligonucleotides needed to be synthesized. One extreme is that each subgroup will have only one member and thus no randomization is needed. Hence, the lowest complexity is achieved and the highest number of oligonucleotides will be synthesized. Obviously a balance during the library design should be considered according to the aims of the study as well as the required downstream process. For example, if the downstream assay is a simple positive selection such as cell survival [10, 12] or FACS sorting [27] , a pooled library can be used effectively and a more complex library would not be problematic. Second, codon preference (e.g., in mammals) was utilized during the reverse translation step to reduce complexity of codon usage during reverse translation according to the weighted preference in mammalian cells, which also significantly reduced the complexity of the library. In the study presented here, however, we have used the extreme case of using the codons that appeared only in the actual genes.
The method described in this report provides a practical solution. First, it simplifies oligonucleotide synthesis and provides a single-step cloning approach, thereby speeding up the process while reducing cost. Second, it allows for the delivery of the RNAi libraries in a pooled fashion, such as the one delivered by lentiviral vectors (Zhou et al., unpublished), as well as in an arrayed format for cotransfection [3] , making the library sufficiently flexible for different combinatorial screenings. Third, it provides a high degree of flexibility in the library design so that the complexity of the library can readily be manipulated according to the study goals. Finally, it also allows for the possibility (via techniques such as inverse genomics) [11, 12, 28] for the discovery of novel members of the gene family of interest.
We first created a NHR siRNA library for a proof-ofprincipal study because NHR is a small protein family and contains a readily identified characteristic domain. Although conventional preparation of an arrayed library can be achieved for small groups of genes without particular difficulty, the creation of the NHR library nevertheless validates the general principle for larger gene family libraries. NHRs are considered highly targetable either by agonists or by antagonists, since there are many known natural or synthetic ligands for these genes. It is also an important protein family in regulating gene expression and other critical aspects of cellular physiology and pathology [13, 14] . In a separate screening using this NHR siRNA library, we have used the G6P promoter-luciferase reporter assay to identify receptors in the liver that are involved in regulating gluconeogenesis. In that study, we identified LXRs and RXRs, both already known to regulate G6Pase gene expression [29, 30] , as well as a novel target [31] . Although its effect is relatively sequence-specific, siRNA can tolerate certain mismatches, particularly at both ends. In fact, it has been found that lower thermal stability at the 5′ end of the antisense strand actually increases the siRNA potency [23, 24] . This information is important in guiding the BLAST search using siRNA sequence against the genomic databases to identify the potential candidate targets. On the other hand, "off-target" effects remain an issue, particularly for the library design based on degenerate sequences. We noticed the offtarget effect when only one target (RORC) was confirmed by additional siRNA. Therefore, it is critical to design multiple validation siRNAs, to confirm the candidate target for this type of RNAi library strategy. An alternative approach to reduce the false-negative rate is to design a library against more than one consensus motif.
The hallmark of AD progression is the formation of amyloid deposits, which are thought to cause neuronal cell degradation [15] . Amyloid plaques are primarily made of the toxic amyloid β peptides Aβ40 and Aβ42 which are generated by cleavage by β-and γ-secretases. This amyloid hypothesis is one of the most accepted AD etiology theories at present. Our goal is to reduce the toxic peptides by enhancing cleavage between the β-and the γ-secretase sites. We identified RORC as a potential gene target whose inactivation can increase cleavage of the toxic Aβ peptides. The confirmation that the RORC inactivation indeed reduced the overall toxic Aβ peptide levels suggests the relevance of Aβ cleavage upstream of the major γ-secretase sites to the reduction of the overall toxic peptide levels. Although the level was modest, it was suggested that a slight reduction in Aβ42 levels, especially if it lowers the ratio of the toxic Aβ42 to Aβ40 and other cleavage products, could significantly benefit patients. Therefore, this discovery of RORC as a possible target for Aβ degradation could open a potential novel avenue for AD therapeutics development.
Northern blot analysis has revealed that the 3.2-kb ROR-γ transcript is expressed at the highest levels in skeletal muscle and at lower levels in various other tissues [32] . In silico data from the NCBI database reveals ROR-γ mRNA expression in many brain regions, although there are no data on AD patients. Many experiments can be performed to verify further whether RORC is relevant to Aβ degradation in brain. An adequate cellbased assay such as assays to check the downstream effects of RORC on the activity of certain enzymes, e.g., MMP-9, IDE, and neprilysin, or ultimately in vivo silencing of ROR-γ in an AD animal model could provide the valuable validation information. If RORC is proven to be a suitable drug target for AD, new RORC-specific antagonists, particularly those that can pass the blood-brain barrier, could be identified for potential therapeutics and prevention of AD.
Materials and methods

Cells
The HEK293 cell line was obtained from ATCC and cultured in Dulbecco's modified Eagle's medium (Invitrogen, Carlsbad, CA, USA), supplemented with 10% fetal bovine serum (Invitrogen), 2 mM L-glutamine (Fisher Scientific), 1× nonessential amino acids (Irvine Scientific, Santa Ana, CA, USA), and 1% sodium pyruvate (Invitrogen).
APP695sw stable cells overexpressing Swedish mutant amyloid precursor protein were generated by stable cotransfection of APP695sw expression plasmid and pcDNA3 vector (to provide a G418 selection marker) into HEK293T cells followed by selection with G418. A single cell clone named 1D11 secreting high levels of Aβ42/40 detected by ELISA was chosen for the experiment. The APPsw695 mutant allele was isolated from a familial AD patient who was shown to generate high levels of the toxic Aβ fragments Aβ42 and Aβ40 [18] [19] [20] .
Vector construction Construction of the NHR RNAi library arrayed in 96 wells
The construction of pHUMU vector was previously described [3] . The nine different oligos of 21-mers (Table 2 ) plus flanking sequences (see Fig.  1 ) were chemically synthesized (IDT) and were pooled according to their weight within the family. The oligos were annealed with adaptor oligos to form a partially double stranded and partially single-stranded structure, which was subsequently ligated into the digested pHUMU fragment [3] . The ligated vectors with a single-stranded region in the siRNA sequences were transformed into bacteria. The bacteria were allowed to complete secondstrand synthesis by filling in the single-stranded region in vivo. The libraryvector-transformed bacteria were plated at a density at which the individual colonies were separated from each other. The colonies were harvested as a pooled library and stored at −80°C. To prepare for the arrayed library, ∼4800 colonies were picked and cultured separately in 1.8-ml 96-well plates (Qiagen) overnight and until the end of log phase to ensure similar ODs. Each of 10 well cultures was pooled and the plasmids were prepared from them using Qiagen DNA prep kits, and the DNAs were arrayed into five 96-well plates. DNA concentrations were measured with the PicoGreen Assay (Invitrogen) and normalized to 0.1 μg/μl, ready for screening purposes.
Construction of pNotch-AβMV
pCxNC53NICD and pGV-B-HES-1 were obtained from Dr. Komano. pNotch-AβMV was constructed by the following procedure. First, a murine Igκ-chain V-J2-C signal peptide DNA fragment was generated by PCR using the primer pair 5′-ATCTGGTACCTCCACCATGGAGACAGAC-3′ and 5′-ATCTGGTACCGAGATCTGGCCGGCTGG-3′. Second, this fragment and the hemagglutinin A epitope from pDisplay (Invitrogen) were added to the N-terminal of the Aβ peptide using a KpnI restriction site in pCxNC53NICD. Furthermore, two point mutations were introduced into the Aβ sequence to disrupt the major γ-secretase cleavage by site-directed mutagenesis at positions 41 and 42 using primers 5′-ATGGTGGGCGGTGTTGTCatggtgACAGTGATCGTCATCACCT-3′ and 5′-AGGTGATGACGATCACTGTcaccatGACAACACCGCCCACCAT-3′ (lowercase indicates the mutated sites) according to the protocol of the Quikchange site-directed mutagenesis kit (Stratagene).
Other constructs
The SV40-Renilla luciferase expression vector was purchased from Promega (Madison, WI, USA); NEP expression plasmid was kindly provided by Dr. Shiotani. IDE and PSN expression plasmid was cloned from a cDNA library (Clontech, Palo Alto, CA, USA) by PCR and inserted into the expression plasmid pcDNA vector (Invitrogen); APP695wt (wild type) expression plasmid was generated by PCR from APP770 expression plasmid that was purchased from Origene. The primers used for PCR were 5′-TCTGTGGAAGAGGTGGTTCGAGTTCCTACAACAGCAGCCAG-TACC-3′ and 5′-GGTACTGGCTGCTGTTGTAGGAACTCGAAC-CACCTCTTCCACAGA-3′. APP695sw (Swedish mutant) and APP695MV (γ-secretase mutant) were generated from APP695wt by a site-directed mutagenesis kit (Stratagene). The primers for generated APP695sw were 5′-GAGGAGATCTCTGAAGTGaatctgGATGCAGAATTCCGACAT-3′ and 5′-ATGTCGGAATTCTGCATCcagattCACTTCAGAGATCTCCTC-3′. All the constructs were confirmed by sequencing analysis.
Transgene or siRNA plasmid vector cotransfection, luciferase assay, and human nuclear hormone siRNA library screening Cotransfection of four plasmids, pNotch-AβMV (50 ng/well), pHES-Luc, SV40-Renilla (5 ng/well) (Fig. 2B, 1-3) , and one of the various transgene vectors (e.g., pNEP and pcDNA-PSN and IDE) (150 ng/well) into HEK293T cells in 96-well plates was carried out as previously described [3] . Briefly, the cells were seeded in 96-well plates (12,000 cells per well) on day 1 and transfected on day 2 with these four plasmids using LT1 (0.5 μl/well) in a total transfection volume of 25 μl in OptiMem medium (Invitrogen). Luciferase activity was measured on day 4 using the Dual-Luciferase kit as instructed by the manufacturer. pHUMU-siRNA library vector screening was performed essentially the same way as for the above four-plasmid vector cotransfection (Fig. 2B, 1-4) , except that the transgene plasmid vector was replaced with the siRNA library.
Transfection of HEK293T with siRNA
The siRNAs were purchased from Dharmacon. The siRNA transfection was previously described [21] . The siRNA sequences were (1) NR1I3 NM_005122, #1_sense, 5′-CCUCUUCGCUACACAAUUGUU, antisense, 5′-P-CAAUUGUGUAGCGAAGAGGUU; (2) NR1I3 NM_005122, #2_sense, 5′-GAACAGUUUGUGCAGUUUAUU, antisense, 5′-pUAA-ACUGCACAAACUGUUCUU; (3) RORC, NM_005060, #1_sense, 5′-UCACCGAGGCCAUUCAGUAUU, antisense, 5′-pUACUGAAUGGC-CUCGGUGAUU; (4) RORC, NM_005060, #2_sense, 5′-AGAACAGCUG-CAGUACAAUU, antisense, 5′-pUACUGAAUGGCCUCGGUGAUU; (5) NR6A1, NM_001489, #1_sense, 5′-CAACGAACCUGUCUCAUUUUU, antisense, 5′-pAAAUGAGACAGGUUCGUUGUU; (6) NR6A1, NM_001489, #2_sense, 5′-GAAGAACUACACAGAUUUAUU, antisense, 5′-pUAAAUCUGUGUAGUUCUUCUU; (7) NR4A2, BC_066890, sense, 5′-GAGAGUGGAAGAACUGCAAUU, antisense, 5′-pUUGCAGUUCUUCCACUCUCUU.
Gene expression analysis
TaqMan real-time PCR was performed as previously described [21] . Briefly, total RNA was isolated from different cell lines using the RNeasy kit (Qiagen) according to the manufacturer's protocol. Real-time RT-PCR (TaqMan) was carried out using the Prism 7700 sequence detector (Applied Biosystems) and dual-labeled fluorescent probe and PCR primers targeting the human ROR-γ coding region (probe, 5′-6FAM/AGTTCGCCAAGAGGCTCTCAGGCTTT/ 3BHQ; forward primer, 5′-CTCACCGAGGCCATTCAGTAC-3′; reverse primer, 5′-CTGGTCATTCTGGCAGAGCTC-3′). Each RNA sample was analyzed in triplicate in two independent assays of RT-PCR with reaction consisting of the following steps: hold 48°C × 30 min; 95°C × 15 s and 60°C × 1 min for 40 cycles. The relative PLK mRNA levels were normalized to the level of the 18S rRNA internal control (Applied Biosystems).
ELISAs for Aβ40 and toxic Aβ42 peptides
ELISAs for toxic Aβ42 and Aβ40 peptides were carried out using standard ELISA procedures. Briefly, culture media were collected and cell debris was removed by centrifugation. Aβ40 and Aβ42 levels were quantified by sandwich ELISA according to the manufacturer's instructions (BioSource International, Camarillo, CA, USA). All the measurements were performed in triplicate.
